MasterControl, a leading provider of manufacturing and quality management software solutions for regulated industries, announced the launch of GxPAssist AI, a suite of purpose-built generative artificial intelligence (AI) tools for quality and manufacturing professionals. These tools deliver practical benefits, helping to streamline many processes that allow manufacturers to safely...
CustomerInsights.AI (CIAI) is excited to announce a strategic collaboration with Ikigai Labs to explore the potential of pharma-specific enterprise grade GenAI for structured data sets. This collaboration aims to address critical use-cases in the pharmaceutical industry, including integrated sales forecasting, call routing, resource planning, pharmacy fraud detection, and automated data matching...
Rezo Therapeutics, a biotechnology company pioneering the integrated mapping of disease networks for precision therapeutics, announced the appointment of Cristiana Guiducci, Ph.D., as chief scientific officer. Dr. Guiducci previously served as senior vice president of immunology and oncology research of Nurix Therapeutics and has nearly 20 years of experience...
Brainomix, a pioneer in artificial intelligence (AI) imaging solutions, has announced it has entered into a partnership with German pharmaceutical company Boehringer Ingelheim for a collaborative programme of activity to improve the care of patients with fibrosing lung disease in the US.
This landmark project will focus on the opportunity for AI...
COTA, Inc., in collaboration with Texas Oncology’s Precision Health Informatics, LLC (PHI), announces an innovative collaboration aimed at revolutionizing precision medicine across Texas Oncology’s community cancer centers. Leveraging COTA’s AI-powered curation engine, CAILIN™, this collaboration will transform fragmented healthcare data into actionable insights.
Unlocking Insights from Electronic Health Records (EHRs)
Electronic...
Subtle Medical's new software is now available for clinical use in the US, further redefining the speed and quality of accelerated MRI
Subtle Medical, a leading healthcare technology company using AI to improve medical imaging, announced FDA clearance of their new software solution, SubtleSYNTH™, which uses deep learning (DL) to generate...
nference announced a strategic research alliance with Takeda aimed at harnessing artificial intelligence (AI) to optimize patient care in inflammatory bowel disease (IBD), a chronic gastrointestinal disorder affecting millions globally.
The collaboration, known as Project SUCCINCT (Systematic UC & Crohn’s INformatics Clinical Toolkit), will utilize nference’s advanced machine learning models to analyze de-identified electronic health records....
The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list.
Hyperfine, the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance brain imaging system—the Swoop® system—announced the clearance of the ninth generation...
CytoReason, a leader in developing computational disease models for predictive insights, announced it secured an aggregated $80 million from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific.
CytoReason will use this investment to expand the application of its models into additional indications, grow its proprietary molecular and clinical data, and establish...
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, announced that its multimodal immune profile score (IPS) algorithmic test is now available for research use only (RUO). IPS is the first offering of a larger immunotherapy-based portfolio being developed at Tempus to bring next-generation algorithmic diagnostics to...
